A simple supplement could help the immune system fight cancer and viruses
Research from Rockefeller University indicates that arginine, an amino acid, may enhance immune response against cancer and viruses by restoring the production of MHC-1 proteins. Low levels of arginine have been linked to weakened immune systems and increased mutations in colon cancer cells. The study suggests that arginine supplementation could be tested as a therapeutic option for patients undergoing immunotherapy or for high-risk populations exposed to viral infections.